• DOI:10.1002/mds.27438
Corpus ID: 52294141

Neurobiology of placebo effect in Parkinson's disease: What we have learned and where we are going

@article{Quattrone2018NeurobiologyOP,
  title={Neurobiology of placebo effect in Parkinson's disease: What we have learned and where we are going},
  author={A. Quattrone and G. Barbagallo and A. Cerasa and A. Stoessl},
  journal={Movement Disorders},
  year={2018},
  volume={33}
}

• A. Quattrone, G. Barbagallo, +1 author A. Stoessl
• Published 2018
• Medicine
• Movement Disorders

The placebo effect is a phenomenon produced when an inert substance administered like a regular treatment improves the clinical outcome. Parkinson's disease (PD) is one of the main clinical disorders for which the placebo response rates are high. The first evidence of the neurobiological mechanisms underlying the placebo effect in PD stems from 2001, when de la Fuente‐Fernandez and colleagues demonstrated that a placebo injection led to the release of dopamine in the striatal nuclei of PD… Expand